Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

10,423 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Limited Protection of Inactivated SARS-CoV-2 Vaccine against Wuhan Strain and Variants of Concern.
Hunsawong T, Fernandez S, Buathong R, Khadthasrima N, Rungrojchareonkit K, Lohachanakul J, Suthangkornkul R, Tayong K, Huang AT, Klungthong C, Chinnawirotpisan P, Poolpanichupatam Y, Jones AR, Lombardini ED, Wacharapluesadee S, Putcharoen O. Hunsawong T, et al. Among authors: jones ar. Emerg Infect Dis. 2021 Sep 24;27(12). doi: 10.3201/eid2712.211772. Online ahead of print. Emerg Infect Dis. 2021. PMID: 34559045
Characterising proteolysis during SARS-CoV-2 infection identifies viral cleavage sites and cellular targets with therapeutic potential.
Meyer B, Chiaravalli J, Gellenoncourt S, Brownridge P, Bryne DP, Daly LA, Grauslys A, Walter M, Agou F, Chakrabarti LA, Craik CS, Eyers CE, Eyers PA, Gambin Y, Jones AR, Sierecki E, Verdin E, Vignuzzi M, Emmott E. Meyer B, et al. Among authors: jones ar. Nat Commun. 2021 Sep 21;12(1):5553. doi: 10.1038/s41467-021-25796-w. Nat Commun. 2021. PMID: 34548480 Free article.
Fc-engineered antibody therapeutics with improved anti-SARS-CoV-2 efficacy.
Yamin R, Jones AT, Hoffmann HH, Schäfer A, Kao KS, Francis RL, Sheahan TP, Baric RS, Rice CM, Ravetch JV, Bournazos S. Yamin R, et al. Among authors: jones at. Nature. 2021 Sep 21. doi: 10.1038/s41586-021-04017-w. Online ahead of print. Nature. 2021. PMID: 34547765
10,423 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page